Authored By: Sarah
07 Nov 2024

increasing prevalence of critical care conditions is driving the Syringe And Needle Market

Latest News:- Syringe And Needle Market: Hospitals and clinics is expected to lead the End-user segment during 2024-2028

Technavio analyzes that the Syringe And Needle Market is expected to grow at a CAGR of 7% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 7352.7 million.There are various factors that contribute to the growth of the market. The global syringe and needle market is witnessing significant growth due to the increasing prevalence of critical care conditions and chronic diseases. These medical devices are essential for administering medications, collecting samples, and performing diagnostic procedures. The rising number of hospitals and clinics, coupled with advancements in medical technology, is further fueling market expansion. Additionally, the growing geriatric population and increasing focus on preventive healthcare are expected to provide ample opportunities for market growth. Despite these positive factors, the market faces challenges such as stringent regulatory requirements and rising raw material costs. Nonetheless, the syringe and needle market is poised for robust growth in the forecast period.

The global syringe and needle market holds significant importance in the healthcare industry, particularly in hospitals and clinics, due to their extensive use in administering vaccines, anticoagulants, biologics, and injectable drugs for both chronic therapies and infectious diseases. Healthcare professionals prefer syringes and needles for their advantages, including ease of administration, precise dosing, and extended storage capabilities. Major organizations, such as the European Board of Anaesthesiology (EBA), the National Patient Safety Agency, and the Association of Anaesthetists of Great Britain and Ireland, advocate for the utilization of syringes and needles in all applications to ensure patient safety and efficacy. The World Health Organization (WHO) also emphasizes the importance of adequate vaccine doses and proper administration techniques, further increasing the demand for these essential medical tools. In the context of cardiovascular diseases and other chronic conditions, syringes and needles play a crucial role in delivering injectable drugs for effective treatment and management. 

Know which region is leading the market growth by requesting a sample report

Syringe And Needle Market Segmentation

  • End-user
    • Hospitals and clinics
    • Home care
    • Others
  • Geography
    • North America
    • Europe
    • APAC
    • South America
    • Middle East and Africa

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • Aurobindo Pharma Ltd.
  • Avanos Medical Inc.
  • B.Braun SE
  • Becton Dickinson and Co.
  • Cardinal Health Inc.
  • Catalent Inc.
  • CODAN Medizinische Gerate GmbH and Co KG
  • GBUK Group Ltd.
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Medela AG
  • Medtronic Plc
  • Nipro Corp.
  • Pfizer Inc.
  • Retractable Technologies Inc
  • SCHOTT AG
  • Smiths Group Plc
  • Teleflex Inc.
  • Terumo Corp.
  • Thermo Fisher Scientific Inc.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The global Syringe and Needle market is witnessing significant growth due to the increasing demand for vaccinations and chronic disease treatments. Drug Delivery Technology plays a crucial role in the market, with a focus on Pre-filled Syringes (PFS) and Safety Syringes. Hospitals and healthcare systems are major consumers, especially for infectious diseases like HIV, Hepatitis B & C, and vaccines for Long-term Diseases such as Diabetes, Cardiovascular Disease, and Cancer. Outpatient treatments and chronic therapies are also driving market growth. The World Health Organization emphasizes the importance of vaccinations to prevent Viral Transmission, and the AsiaPacific markets are expected to lead in Injectable Development due to their large Geriatric population. Roche Diabetes Care and other key players are investing in innovative solutions to reduce Needle Stick Injuries and improve Drug Delivery. The market includes vaccine production and injectable drugs for various diseases, including Infectious Diseases and Chronic Diseases.

Market Research Overview

The global healthcare supplies market encompasses businesses involved in the research and development (R&D) of a diverse range of medical consumables, including syringes, pre-filled syringes (PFS), blood collection syringes, drapes, gloves, and gowns. According to Technavio, market size is determined by the consolidated revenue generated by these manufacturers. Key growth drivers for this sector include the rising prevalence of long-term diseases such as cancer, cardiovascular diseases, diabetes, and infectious diseases, which necessitate frequent vaccinations and drug delivery technologies. With an aging population, particularly in regions like Europe and the US, the demand for healthcare supplies is projected to surge significantly by 2030-2050, as nearly one-quarter of these populations reach the age of 60.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.